Certain Series A Preferred stock of Idera Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 5-JAN-2017. These Series A Preferred stock will be under lockup for 90 days starting from 7-OCT-2016 to 5-JAN-2017. Details: The officers and directors and the Pillar Investment Entities have agreed that for a period of 90 days from the date of the prospectus that they will not dispose of or hedge 18,847,816 shares of common stock or any securities convertible into or exchangeable for common stock without the prior written consent of the Goldman, Sachs & Co. and J.P. Morgan Securities LLC.